Mexolan

Meloxicam, the active ingredient in Mexolan, is a nonsteroidal anti-inflammatory drug presented as a injectable solution for intramuscular use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions.

GNH USA supplies Mexolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is used to manage pain and inflammation in musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: alleviates inflammatory joint symptoms. - Acute pain: provides short‑term relief of moderate to severe pain. - Post‑operative pain: helps control pain after surgical procedures.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: feeling of light‑headedness or unsteadiness. - Injection site reactions: erythema, swelling or pain at the intramuscular site.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: serious stomach or intestinal lesions. - Cardiovascular events: increased risk of heart attack or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before using Mexolan, consider the following precautions to minimize risks.

- Renal function: assess kidney status, especially in patients with existing impairment. - Cardiovascular risk: avoid in individuals with recent myocardial infarction or uncontrolled hypertension. - Gastrointestinal history: use cautiously in patients with ulcer disease or bleeding. - Concomitant anticoagulants: monitor for increased bleeding tendency. - Pregnancy and lactation: avoid use unless clearly needed, as safety is not established. - Store at ambient temperature: keep below 25°C, protect from moisture and light, retain in original packaging.

Meloxicam can interact with several medicines; awareness of these interactions helps ensure safe therapy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated chance of bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function. - Diuretics: potential for decreased kidney perfusion. - Lithium: NSAIDs can raise lithium serum levels. - Methotrexate: reduced clearance may increase toxicity.